Evaluations of serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak
Detection Principle
ImmunoAssay-Antibody
Target
IgM/IgG on N-protein
Testing Method Category
Testing Method
In-house method and individual kit
Testing Method - Additional Info
Kit: Daraui Biotech
Reported Performance
Sensitivity: 81.25% (IgM in house), 97.5% (IgG in house)
Sample Size
159 patients
Peer-reviewed
no
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements